Publication | Closed Access

Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study

Phase Ii TrialMedicineCancer ManagementMetronomic TherapyGynecologyCombination BevacizumabCancer TreatmentOncologyRadiation OncologyPersistent Endometrial CarcinomaGynecology Oncology